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middle ear was also studied.
The levels of antigen-specific IgG, IgA and IgM showed extensive inter-individual variation. No significant difference in anti-M. catarrhalis and S. pneumoniae serum and MEF MFI values (anti-M. catarrhalis and anti-pneumococcal IgG levels) was observed between the rAOM or COME groups for all antigens tested.
No significant difference was observed for M. catarrhalis and S. pneumoniae colonization and serum IgG levels against the Moraxella and pneumococcal antigens. Similar to the antibody response in serum, no significant difference in IgG, IgA and IgM levels in MEF was observed for all M. catarrhalis and S. pneumoniae antigens between OM M. catarrhalis or S. pneumoniae positive and OM M. catarrhalis or S. pneumoniae negative children suffering from either rAOM or COME. Finally, results indicated a strong correlation between antigen-specific serum and MEF IgG levels.
We observed no significant in vivo expressed anti-M. catarrhalis or anti-S. pneumoniae humoral immune responses using a range of putative vaccine candidate proteins.
Other factors such as Eustachian-tube dysfunction, viral load, and genetic and environmental factors may play a more important role in the pathogenesis of OM, and in particular in the development of rAOM or COME.
INTRODUCTION
Otitis media (OM) is an important upper respiratory tract disease of early childhood and the primary reason for young children to visit a physician. The disease has a considerable negative impact on the quality of life during childhood and causes much concern to parents.
OM encompasses a spectrum of conditions, including acute otitis media (AOM) and otitis media with effusion (OME), with approximately 80% of children having experienced an episode of AOM by the age of three years. Up to one-third of these children will have experienced recurrent infections, with many of these episodes being facilitated by a bacterial infection (3, 37) . In fact, bacteria may be isolated from the middle ear fluid (MEF) of approximately 80% of children with AOM, and 30-50% of chronic middle ear effusions obtained from children presenting with OME (12) . In many countries, OM is a common reason to prescribe antibiotics or to undergo surgery for the insertion of ventilation tubes, resulting in a significant burden on healthcare systems (21, 25, 29) . This means that the direct costs associated with OM are substantial (2) , and that the prevention of OM disease via alternative methods such as vaccination offer a promising approach to reduce the burden of OM disease and its economic consequences.
Traditionally, Streptococcus pneumoniae has been reported to be the predominant bacterial species cultured in AOM disease, followed by Haemophilus influenzae and Moraxella catarrhalis. However, H. influenzae tends to predominate in OME disease, followed to a lesser extent by S. pneumoniae and M. catarrhalis (7, 9, 32) . Further, although these common OM-related bacterial species may be cultured from the middle ear of children during OM episodes, either as single pathogens or as co-cultures (28) , research has also shown the importance of (frequently culture negative) bacterial biofilm formation in the development of middle ear disease (22) . Finally, the introduction of a conjugated heptavalent pneumococcal vaccine (PCV7) for use in children in the community has resulted in a 5 significant reduction in the overall proportion of S. pneumoniae isolates and vaccine serotypes observed in AOM. Indeed, the success of vaccination against S. pneumoniae now means that H. influenzae is now becoming the predominant pathogen isolated from children suffering from persistent AOM disease (6, 10) .
Children are frequently colonized with bacterial pathogens at an early age and the pattern of nasopharyngeal colonization is an important determinant for OM disease (15) (16) .
Further, research has also indicated that, as well as the presence of particular bacterial species, both the adaptive and innate immune systems, Eustachian-tube dysfunction, viral load, and genetic and environmental factors all may be involved in the pathogenesis of OM (19, 23, 30-31, 33, 38) .
The recent recognition of M. catarrhalis as an important human pathogen has stimulated active investigation into the molecular mechanisms of its pathogenesis. An essential step in colonization and infection is bacterial adherence to the mucosal epithelium of the respiratory tract. A growing number of adhesins have been identified in M. catarrhalis and most of these proteins are highly conserved, immunogenic and express distinct epitopes on the bacterial surface. This means that they may be suitable as potential M. catarrhalis vaccine candidates (27) . However, relatively little is known regarding the development of the natural humoral immune response to these potential vaccine candidates in children. As yet, no licensed vaccine has been marketed against M. catarrhalis, and to date, none of the putative vaccine candidates so far described in the literature have actually progressed to clinical trials.
On the other hand, vaccination against S. pneumoniae infection is already established, for example via the introduction of the PCV7 vaccine. PCV7 was primarily used to prevent invasive pneumococcal disease (meningitis and other pneumococcal infections such as pneumonia) in children, with the introduction of PCV7 having lead to a noticeable reduction 6 in the incidence of S. pneumoniae vaccine strains in the etiology of AOM (13). However, an increase in the carriage of non-vaccine serotypes has been reported, as well as a consequent increase in invasive disease by these non-vaccine serotypes, which could reduce, or even negate the benefits initially obtained through vaccination with PCV7 (11, 26) . In fact, S. pneumoniae serotype replacement and subsequent vaccine failure in PCV7 vaccinated children has become a serious concern in recent years, with most of these problems assigned to the serotype specific nature of the PCV7 vaccine. Currently, several pneumococcal surface proteins, either alone or in combinations, have been suggested as putative vaccine candidates (1, 13, 20) , and could serve as more effective vaccines than those currently available, providing broad coverage against most pneumococcal serotypes. However, similar to the situation faced by vaccine candidates of M. catarrhalis, relatively little is known about the development of the humoral immune response to S. pneumoniae protein-based vaccine candidates in children.
With this study, we provide insights into the anti-M. catarrhalis and antipneumococcal humoral immune response in a cohort comprising Dutch children exhibiting recurrent (recurrent acute otitis media, rAOM) and chronic (chronic otitis media with effusion, COME) episodes of OM. Currently, there is a common perception that rAOM tends to be caused by recurrent episodes of AOM that are associated with bacteria and/or viral infections. In contrast, COME is generally considered a sterile inflammation. Studying the immune response and the accompanying pathogens associated with rAOM and COME will allow us to better distinguish the types of bacterial and immune factors that are involved in the pathogenesis of rAOM and COME, and leading to a better understanding of the pathogenesis of these 2 clinical presentations of OM disease.
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MATERIALS AND METHODS
Study cohort
This study was performed as part of a prospective clinical cohort study set up at Radboud 
Clinical materials and detection of bacterial pathogens
Middle ear fluid, a nasopharyngeal swab and serum were collected during surgery. 
Streptococcus pneumoniae antigens
The previously described S. pneumoniae recombinant proteins used in this study comprised: 
Statistical analysis
Statistical analyses were performed using SPSS PASW Statistics version 17. Correlations between antigen-specific IgG in serum and MEF were assessed using Spearman's correlation coefficient. The Mann-Whitney U-test was used to compare anti-M. catarrhalis and antipneumococcal immunoglobulin (Ig) levels between children diagnosed with rAOM and COME and to compare differences in Ig levels between colonized and non-colonized children. The Bonferroni correction was applied to correct for multiple testing. A P-value of ≤0.00064 was considered to be statistically significant.
RESULTS
Correlation between anti-M. catarrhalis and anti-pneumococcal IgG levels in serum and
MEF
To determine the correlation between the levels of anti-Moraxella and anti-pneumococcal Differences in the presence / absence and levels of pathogen-specific IgG and IgM at particular body sites may be one of the mechanisms by which OM pathogens are able to facilitate the development of OM disease. In this study, no significant difference in anti-M.
catarrhalis and anti-S. pneumoniae serum and MEF IgG levels was observed between the rAOM or COME groups for all antigens tested, suggesting that differences in IgG levels between body sites does not play a significant role in the development of rAOM or COME disease. Interestingly however, a strong correlation was observed between IgG antibody levels in serum and IgG antibody levels in MEF, for both M. catarrhalis and pneumococcal
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proteins for the whole study cohort. This is an interesting finding, as it indicates that serum antibody levels are predictive of the presence of local (middle ear) IgG antibody (14, 17) , and raises the possibility that the measurement of OM pathogen-specific IgG antibodies in the middle ear may be achieved by simply measuring OM pathogen-specific serum IgG antibody levels in serum. At this moment in time however, it is not known whether OM pathogenspecific IgG is actually produced locally in the middle ear or transudes into the middle ear from the general circulation (4, 14) . From our results, it appears more likely that OM pathogen-specific IgG actually transudes into the middle ear rather than being locally produced, where it potentially provides some protection against OM disease. No significant difference in anti-M. catarrhalis and anti-S. pneumoniae MEF IgM levels was observed for either rAOM or COME cohort in this study.
The local production of secretory antibody is an important immunological defense at epithelial surfaces including the surfaces of the upper respiratory tract and middle ear.
Secretory IgA has been shown to inhibit S. pneumoniae adherence and reduce nasopharyngeal bacterial colonization (18), and it is therefore possible that children with recurrent OM might lack OM pathogen-specific secretory IgA. In this study, the MFI levels of antigen-specific IgA showed extensive inter-individual variability over time, with IgA levels to all M. catarrhalis and S. pneumoniae OMPs being relatively low throughout the study period. However, though not significant, S. pneumoniae-negative / COME-positive children showed higher MEF IgA levels against the pneumococcal IgA-1 protease protein compared to S. pneumoniae-positive / COME-positive children. In fact, many mucosal pathogens, including S. pneumoniae, express an IgA-1 protease that cleaves IgA molecules, thereby circumventing the protective effects of IgA production (40) . Our results suggest that
IgA antibody directed against anti-IgA-1 protease may have a restorative effect by helping 'neutralizing' the effect of secreted anti-IgA-1 protease, thereby facilitating the binding of 14 intact IgA to bacterial cells and promoting pathogen recognition and clearance by the immune response. However, it should be noted that the possibility exists that the differences in antibody levels observed in S. pneumoniae positive and negative COME MEFs are simply a product of antibody binding to S. pneumoniae bacterial cells, thereby making the antibodies inaccessible to measurement using our Luminex assay. Further research will be required in order to determine whether IgA-1 protease antibodies actually provide protection in patients suffering from OM disease.
Studying the immune response and pathogens associated with rAOM and COME disease indicated that COME is not in fact a sterile inflammation as is generally considered the case. Importantly, investigation into the immune response to potential vaccine candidates of M. catarrhalis and S. pneumoniae indicated that there may be a lack of a characteristic immune response profiles that will allow clinicians to distinguish between rAOM and COME. Our data correlate with the findings of Stol et al., who investigated bacterial colonization and infection in the nasopharynx and middle ear of the same prospective cohort of children and found no clear-cut differences in the microbial flora present in middle ear fluids obtained during rAOM and COME disease.
In summary, the levels of antigen-specific serum IgG and MEF IgG / IgM / IgA showed extensive inter-individual variation in our rAOM and COME cohort of children, with no significant differences between the 2 groups. Both rAOM and COME children possessed a range of antibodies (IgG, IgA and IgM) against a variety of novel M. catarrhalis and S.
pneumoniae recombinant proteins, and there were no distinguishing immune response profiles observed between the 2 groups. Factors such as Eustachian-tube dysfunction, viral load, and genetic and environmental factors may play a more important role in the pathogenesis of rAOM and COME disease than the humoral immune response to OMassociated bacterial pathogens.
